Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
University Health Network, Toronto
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
Essen Biotech
St. Jude Children's Research Hospital
MacroGenics
Indiana University
City of Hope Medical Center
University of Florida
M.D. Anderson Cancer Center
Immatics US, Inc.
University of Southern California
Swiss Cancer Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center
Transgene
HiFiBiO Therapeutics
Seattle Children's Hospital
Bayer
GlaxoSmithKline
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Hadassah Medical Organization
Valo Therapeutics Oy
Guangzhou FineImmune Biotechnology Co., LTD.
Institut Claudius Regaud
Iovance Biotherapeutics, Inc.
Eli Lilly and Company